Prostate cancer

Open Access
Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome
JAROSLAV JURACEK, MARIE MADRZYK, KAROLINA TRACHTOVA, MICHAELA RUCKOVA, JULIA BOHOSOVA, DOMINIK A. BARTH, MARTIN PICHLER, MICHAL STANIK and ONDREJ SLABY

Cancer Genomics & Proteomics May 2023, 20 (3) 308-316; DOI: https://doi.org/10.21873/cgp.20383
Open Access
Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis
AKINORI MINATO, YUZAN KUDO, HIROTSUGU NOGUCHI, SHIRO KOHI, YOSHITAKA HASEGAWA, NORIHIRO SATO, KEIJI HIRATA and NAOHIRO FUJIMOTO

Cancer Genomics & Proteomics March 2023, 20 (2) 203-210; DOI: https://doi.org/10.21873/cgp.20375
Open Access
Sex Hormone-regulated CMG2 Is Involved in Breast and Prostate Cancer Progression
ZIQIAN FANG, CHARLOTTE KILLICK, CERITH HALFPENNY, NATASHA FREWER, KATHRYN A. FREWER, FIONA RUGE, WEN G. JIANG and LIN YE

Cancer Genomics & Proteomics November 2022, 19 (6) 703-710; DOI: https://doi.org/10.21873/cgp.20353
Open Access
Nuclear Respiratory Factor 1 Overexpression Inhibits Proliferation and Migration of PC3 Prostate Cancer Cells
CHUN-HSIEN WU, PEI-FANG HSIEH, YEN-HSI LEE, WADE WEI-TING KUO, RICHARD CHEN-YU WU, YUNG-YAO LIN, CHIH-HSIN HUNG, MING-LIN HSIEH, SEE-TONG PANG, YU-LIN YANG and VICTOR C. LIN

Cancer Genomics & Proteomics September 2022, 19 (5) 614-623; DOI: https://doi.org/10.21873/cgp.20346
Open Access
Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts
ANNA SANCHEZ, FRÉDÉRIQUE PENAULT-LLORCA, YVES-JEAN BIGNON, LAURENT GUY and DOMINIQUE BERNARD-GALLON

Cancer Genomics & Proteomics May 2022, 19 (3) 339-349; DOI: https://doi.org/10.21873/cgp.20324
Open Access
Role of Genetic Variations in CDK2, CCNE1 and p27^KIP1 in Prostate Cancer
MÁRK HÍVEŠ, JANA JUREČEKOVÁ, JÁN KLIMENT, MARIÁN GRENDÁR, PETER KAPLÁN, RÓBERT DUŠENKA, DANIEL EVIN, MARTA VILČKOVÁ, KLAUDIA HÍVEŠ HOLEČKOVÁ and MONIKA KMEŤOVÁ SIVOŇOVÁ

Cancer Genomics & Proteomics May 2022, 19 (3) 362-371; DOI: https://doi.org/10.21873/cgp.20326
You have access
SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines
SO YOUNG CHOI, JU MI JEON, ANN YAE NA, OH KWANG KWON, IN HYUK BANG, YUN-SOK HA, EUN JU BAE, BYUNG-HYUN PARK, EUN HYE LEE, TAE GYUN KWON, JUN NYUNG LEE and SANGKYU LEE

Cancer Genomics & Proteomics January 2022, 19 (1) 50-59; DOI: https://doi.org/10.21873/cgp.20303
You have access
MiR-139 Induces an Interferon-β Response in Prostate Cancer Cells by Binding to RIG-1
ROBERT K. NAM, TANIA BENATAR, YUTAKA AMEMIYA and ARUN SETH

Cancer Genomics & Proteomics May 2021, 18 (3) 197-206; DOI: https://doi.org/10.21873/cgp.20252
You have access
PTBP1 Genetic Variants Affect the Clinical Response to Androgen-deprivation Therapy in Patients With Prostate Cancer
SHU-PIN HUANG, LIH-CHYANG CHEN, YEI-TSUNG CHEN, CHENG-HSUEH LEE, CHAO-YUAN HUANG, CHIA-CHENG YU, VICTOR C. LIN, TE-LING LU and BO-YING BAO

Cancer Genomics & Proteomics May 2021, 18 (3) 325-334; DOI: https://doi.org/10.21873/cgp.20263
Open Access
The Association Between the Genetic VDR SNP c.907+75C>T and Prostate Cancer Risk Is Modified by Tanning Potential
DESTA A BEYENE, MOHAMMAD R. DAREMIPOURAN, VICTOR APPREY, TAMMEY NAAB, OLAKUNLE O. KASSIM, ROBERT L. COPELAND and YASMINE M. KANAAN

Cancer Genomics & Proteomics November 2020, 17 (6) 739-745; DOI: https://doi.org/10.21873/cgp.20228

Main menu

User menu

Search

Prostate cancer

Pages